DRTS Alpha Tau Medical | $11.18 +4.7% | 5/20/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 5/20/2026 |
IBRX ImmunityBio | $8.05 +3.7% | 5/20/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 5/20/2026 |
TRAW Traws Pharma | $1.62 +1.9% | 5/20/2026 | | Reiterated Rating | $8.00 | Buy | 00.00% | View details for HC Wainwright rating of Traws Pharma (NASDAQ:TRAW) on 5/20/2026 |
UEC Uranium Energy | $12.75 +7.1% | 5/20/2026 | | Reiterated Rating | $26.75 | Buy | 00.00% | View details for HC Wainwright rating of Uranium Energy (NYSEAMERICAN:UEC) on 5/20/2026 |
VGZ Vista Gold | $2.21 +4.7% | 5/20/2026 | | Reiterated Rating | $4.50 | Buy | 00.00% | View details for HC Wainwright rating of Vista Gold (NYSEAMERICAN:VGZ) on 5/20/2026 |
DWTX Dogwood Therapeutics | $1.84 -0.5% | 5/19/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for HC Wainwright rating of Dogwood Therapeutics (NASDAQ:DWTX) on 5/19/2026 |
GHRS GH Research | $22.54 +2.7% | 5/19/2026 | | Lower Price Target | $70.00 ➝ $65.00 | Buy | 00.00% | View details for HC Wainwright rating of GH Research (NASDAQ:GHRS) on 5/19/2026 |
HYFT MindWalk | $1.59 +26.2% | 5/19/2026 | | Reiterated Rating | $5.00 | Buy | 00.00% | View details for HC Wainwright rating of MindWalk (NASDAQ:HYFT) on 5/19/2026 |
KRRO Korro Bio | $10.01 +9.4% | 5/19/2026 | | Lower Price Target | $20.00 ➝ $15.00 | Buy | 00.00% | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 5/19/2026 |
WVE WAVE Life Sciences | $6.19 +0.8% | 5/19/2026 | | Lower Price Target | $18.00 ➝ $13.00 | Buy | 00.00% | View details for HC Wainwright rating of WAVE Life Sciences (NASDAQ:WVE) on 5/19/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
ALT Altimmune | $2.82 +2.9% | 5/18/2026 | | Reiterated Rating | $25.00 ➝ $20.00 | Buy | 00.00% | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 5/18/2026 |
ZS Zscaler | $174.45 -0.5% | 5/18/2026 | | Upgrade | | Buy | 00.00% | View details for HC Wainwright rating of Zscaler (NASDAQ:ZS) on 5/18/2026 |
CELC Celcuity | $140.34 +7.2% | 5/18/2026 | | Boost Price Target | $165.00 ➝ $185.00 | Buy | 00.00% | View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 5/18/2026 |
NBTX Nanobiotix | $43.16 -6.6% | 5/18/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Nanobiotix (NASDAQ:NBTX) on 5/18/2026 |
UAMY United States Antimony | $8.33 +11.9% | 5/18/2026 | | Boost Price Target | $11.50 ➝ $11.75 | Buy | 00.00% | View details for HC Wainwright rating of United States Antimony (NYSE:UAMY) on 5/18/2026 |
CRCL Circle Internet Group | $111.48 +0.4% | 5/18/2026 | | Upgrade | $85.00 ➝ $150.00 | Neutral ➝ Buy | 00.00% | View details for HC Wainwright rating of Circle Internet Group (NYSE:CRCL) on 5/18/2026 |
ACTU Actuate Therapeutics | $2.51 +4.6% | 5/18/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for HC Wainwright rating of Actuate Therapeutics (NASDAQ:ACTU) on 5/18/2026 |
AIRJ AirJoule Technologies | $3.77 +6.5% | 5/18/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for HC Wainwright rating of AirJoule Technologies (NASDAQ:AIRJ) on 5/18/2026 |
BMRN BioMarin Pharmaceutical | $50.20 +0.8% | 5/18/2026 | | Lower Price Target | $55.00 ➝ $50.00 | Neutral | 00.00% | View details for HC Wainwright rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 5/18/2026 |
CGON CG Oncology | $64.76 +2.3% | 5/18/2026 | | Reiterated Rating | $100.00 | Buy | 00.00% | View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 5/18/2026 |
CTXR Citius Pharmaceuticals | $0.58 +4.7% | 5/18/2026 | | Reiterated Rating | $4.00 | Buy | 00.00% | View details for HC Wainwright rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 5/18/2026 |
INKT MiNK Therapeutics | $10.72 +3.6% | 5/18/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for HC Wainwright rating of MiNK Therapeutics (NASDAQ:INKT) on 5/18/2026 |
KRYS Krystal Biotech | $302.05 +3.0% | 5/18/2026 | | Reiterated Rating | $310.00 | Buy | 00.00% | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 5/18/2026 |
LEGN Legend Biotech | $28.12 +4.4% | 5/18/2026 | | Reiterated Rating | $50.00 | Buy | 00.00% | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 5/18/2026 |
MSLE Satellos Bioscience | $7.36 +5.3% | 5/18/2026 | | Reiterated Rating | $11.00 | Buy | 00.00% | View details for HC Wainwright rating of Satellos Bioscience (NASDAQ:MSLE) on 5/18/2026 |
MTVA MetaVia | $2.89 +53.7% | 5/18/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of MetaVia (NASDAQ:MTVA) on 5/18/2026 |
ORKA Oruka Therapeutics | $60.67 +5.5% | 5/18/2026 | | Reiterated Rating | $120.00 | Buy | 00.00% | View details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 5/18/2026 |
PMI PMI | $0.15 -3.7% | 5/18/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for HC Wainwright rating of PMI (NYSEAMERICAN:PMI) on 5/18/2026 |
PROK ProKidney | $1.69 +9.0% | 5/18/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for HC Wainwright rating of ProKidney (NASDAQ:PROK) on 5/18/2026 |
URGN Urogen Pharma | $30.22 +6.9% | 5/18/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for HC Wainwright rating of Urogen Pharma (NASDAQ:URGN) on 5/18/2026 |
VOR Vor Biopharma | $15.55 +10.0% | 5/18/2026 | | Reiterated Rating | $31.00 | Buy | 00.00% | View details for HC Wainwright rating of Vor Biopharma (NASDAQ:VOR) on 5/18/2026 |
ETON Eton Pharmaceuticals | $34.45 +4.7% | 5/15/2026 | | Boost Price Target | $52.00 ➝ $57.00 | Buy | 00.00% | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 5/15/2026 |
ELVA Electrovaya | $10.19 +7.6% | 5/15/2026 | | Boost Price Target | $10.00 ➝ $15.00 | Buy | 00.00% | View details for HC Wainwright rating of Electrovaya (NASDAQ:ELVA) on 5/15/2026 |
ALMS Alumis | $22.04 +2.4% | 5/15/2026 | | Downgrade | $25.00 | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 5/15/2026 |
ASST Strive | $16.98 +5.1% | 5/15/2026 | | Boost Price Target | $36.00 ➝ $38.00 | Buy | 00.00% | View details for HC Wainwright rating of Strive (NASDAQ:ASST) on 5/15/2026 |
EU enCore Energy | $1.41 +1.4% | 5/15/2026 | | Lower Price Target | $4.00 ➝ $3.75 | Buy | 00.00% | View details for HC Wainwright rating of enCore Energy (NASDAQ:EU) on 5/15/2026 |
KYTX Kyverna Therapeutics | $8.57 -1.5% | 5/15/2026 | | Boost Price Target | $20.00 ➝ $25.00 | Buy | 00.00% | View details for HC Wainwright rating of Kyverna Therapeutics (NASDAQ:KYTX) on 5/15/2026 |
LSTA Lisata Therapeutics | $3.18 +1.9% | 5/15/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Lisata Therapeutics (NASDAQ:LSTA) on 5/15/2026 |
NEUP Neuphoria Therapeutics | $4.93 +3.4% | 5/15/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Neuphoria Therapeutics (NASDAQ:NEUP) on 5/15/2026 |
NPCE NeuroPace | $16.27 +2.6% | 5/15/2026 | | Boost Price Target | $19.00 ➝ $20.00 | Buy | 00.00% | View details for HC Wainwright rating of NeuroPace (NASDAQ:NPCE) on 5/15/2026 |
From the man who predicted 2008 crash… (Ad) Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the biggest story of his 26-year career - an economic shift not seen since 1776.
From the government taking stakes in Intel, Lithium Americas, and MP Materials, to sweeping political changes reshaping the economy, Stansberry argues a rare 'New 1776 Moment' is already underway. One Nobel Prize winner calls it a dividing line for all of society.
His presentation covers the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift. Watch Porter Stansberry's full briefing and learn how to prepare now |
STRO Sutro Biopharma | $31.13 -1.7% | 5/15/2026 | | Boost Price Target | $28.00 ➝ $50.00 | Buy | 00.00% | View details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 5/15/2026 |
ZBIO Zenas BioPharma | $19.56 +9.6% | 5/15/2026 | | Reiterated Rating | $44.00 | Buy | 00.00% | View details for HC Wainwright rating of Zenas BioPharma (NASDAQ:ZBIO) on 5/15/2026 |
IVVD Invivyd | $1.09 +4.8% | 5/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 5/14/2026 |
BIIB Biogen | $187.80 -1.4% | 5/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Biogen (NASDAQ:BIIB) on 5/14/2026 |
PGEN Precigen | $4.27 +2.6% | 5/14/2026 | | Boost Price Target | $10.00 ➝ $11.00 | Buy | 00.00% | View details for HC Wainwright rating of Precigen (NASDAQ:PGEN) on 5/14/2026 |
ASM Avino Silver & Gold Mines | $6.78 +4.6% | 5/14/2026 | | Boost Price Target | $13.00 | Buy | 00.00% | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 5/14/2026 |
AUTL Autolus Therapeutics | $1.62 -0.6% | 5/14/2026 | | Boost Price Target | $9.00 ➝ $10.00 | Buy | 00.00% | View details for HC Wainwright rating of Autolus Therapeutics (NASDAQ:AUTL) on 5/14/2026 |
AVTX Avalo Therapeutics | $16.29 +0.1% | 5/14/2026 | | Lower Price Target | $40.00 ➝ $35.00 | Buy | 00.00% | View details for HC Wainwright rating of Avalo Therapeutics (NASDAQ:AVTX) on 5/14/2026 |
OBIO Orchestra BioMed | $3.98 -0.5% | 5/14/2026 | | Reiterated Rating | $10.00 | Buy | 00.00% | View details for HC Wainwright rating of Orchestra BioMed (NASDAQ:OBIO) on 5/14/2026 |
OMER Omeros | $12.38 +3.4% | 5/14/2026 | | Reiterated Rating | $40.00 | Buy | 00.00% | View details for HC Wainwright rating of Omeros (NASDAQ:OMER) on 5/14/2026 |
TYRA Tyra Biosciences | $33.40 -1.1% | 5/14/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 5/14/2026 |
FEAM 5E Advanced Materials | $1.89 +3.3% | 5/13/2026 | | Set Price Target | $5.75 ➝ $5.50 | Buy | 00.00% | View details for HC Wainwright rating of 5E Advanced Materials (NASDAQ:FEAM) on 5/13/2026 |
TII Titan Mining | $2.37 -0.4% | 5/13/2026 | | Lower Price Target | $6.75 ➝ $6.50 | Buy | 00.00% | View details for HC Wainwright rating of Titan Mining (NYSEAMERICAN:TII) on 5/13/2026 |
CAPR Capricor Therapeutics | $29.01 +7.8% | 5/13/2026 | | Reiterated Rating | $60.00 | Buy | 00.00% | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 5/13/2026 |
FNV Franco-Nevada | $225.28 +1.1% | 5/13/2026 | | Reiterated Rating | $305.00 | Buy | 00.00% | View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 5/13/2026 |
IMNM Immunome | $21.53 +9.5% | 5/13/2026 | | Reiterated Rating | $40.00 | Buy | 00.00% | View details for HC Wainwright rating of Immunome (NASDAQ:IMNM) on 5/13/2026 |
NTLA Intellia Therapeutics | $12.26 +2.7% | 5/13/2026 | | Lower Price Target | $30.00 ➝ $25.00 | Buy | 00.00% | View details for HC Wainwright rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/13/2026 |
SEPN Septerna | $28.01 +5.7% | 5/13/2026 | | Reiterated Rating | $40.00 | Buy | 00.00% | View details for HC Wainwright rating of Septerna (NASDAQ:SEPN) on 5/13/2026 |
AG First Majestic Silver | $19.95 +6.1% | 5/12/2026 | | Boost Price Target | $30.75 | Buy | 00.00% | View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 5/12/2026 |
LQDA Liquidia | $61.77 +3.0% | 5/12/2026 | | Boost Price Target | $55.00 ➝ $67.00 | Buy | 00.00% | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 5/12/2026 |
CLYM Climb Bio | $10.52 +9.0% | 5/12/2026 | | Boost Price Target | $15.00 ➝ $20.00 | Buy | 00.00% | View details for HC Wainwright rating of Climb Bio (NASDAQ:CLYM) on 5/12/2026 |
DRTS Alpha Tau Medical | $11.18 +4.7% | 5/12/2026 | | Boost Price Target | $12.00 ➝ $15.00 | Buy | 00.00% | View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 5/12/2026 |
ITRG Integra Resources | $2.49 +2.9% | 5/12/2026 | | Lower Price Target | $7.00 ➝ $6.75 | Buy | 00.00% | View details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 5/12/2026 |
LENZ LENZ Therapeutics | $7.20 +8.3% | 5/12/2026 | | Lower Price Target | $48.00 ➝ $38.00 | Buy | 00.00% | View details for HC Wainwright rating of LENZ Therapeutics (NASDAQ:LENZ) on 5/12/2026 |
OCS Oculis | $27.91 -0.2% | 5/12/2026 | | Boost Price Target | $44.00 ➝ $47.00 | Buy | 00.00% | View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 5/12/2026 |
RNAC Cartesian Therapeutics | $6.52 +7.1% | 5/12/2026 | | Lower Price Target | $30.00 ➝ $25.00 | Buy | 00.00% | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 5/12/2026 |
SABS SAB Biotherapeutics | $3.68 +3.7% | 5/12/2026 | | Boost Price Target | $7.00 ➝ $10.00 | Buy | 00.00% | View details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 5/12/2026 |
SENS Senseonics Holdings, Inc. Common Stock | $5.71 +3.1% | 5/12/2026 | | Lower Price Target | $18.50 ➝ $14.00 | Buy | 00.00% | View details for HC Wainwright rating of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) on 5/12/2026 |
HRTX Heron Therapeutics | $0.85 -0.4% | 5/11/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Heron Therapeutics (NASDAQ:HRTX) on 5/11/2026 |
IFRX InflaRx | $2.44 +3.0% | 5/11/2026 | | Boost Price Target | $6.00 ➝ $8.00 | Buy | 00.00% | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 5/11/2026 |
TEM Tempus AI | $45.88 +0.8% | 5/11/2026 | | Lower Price Target | $95.00 ➝ $64.00 | Buy | 00.00% | View details for HC Wainwright rating of Tempus AI (NASDAQ:TEM) on 5/11/2026 |
CRBU Caribou Biosciences | $2.00 +1.5% | 5/11/2026 | | Boost Price Target | $9.00 ➝ $11.00 | Buy | 00.00% | View details for HC Wainwright rating of Caribou Biosciences (NASDAQ:CRBU) on 5/11/2026 |
CYTK Cytokinetics | $78.77 +3.0% | 5/11/2026 | | Boost Price Target | $136.00 ➝ $140.00 | Buy | 00.00% | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 5/11/2026 |
URGN Urogen Pharma | $30.22 +6.9% | 5/11/2026 | | Boost Price Target | $40.00 ➝ $45.00 | Buy | 00.00% | View details for HC Wainwright rating of Urogen Pharma (NASDAQ:URGN) on 5/11/2026 |
ANRO Alto Neuroscience | $20.77 +1.5% | 5/11/2026 | | Reiterated Rating | $50.00 | Buy | 00.00% | View details for HC Wainwright rating of Alto Neuroscience (NYSE:ANRO) on 5/11/2026 |
BBIO BridgeBio Pharma | $68.22 +3.4% | 5/11/2026 | | Boost Price Target | $100.00 ➝ $110.00 | Buy | 00.00% | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 5/11/2026 |
CTMX CytomX Therapeutics | $3.72 +2.2% | 5/11/2026 | | Lower Price Target | $17.00 ➝ $11.00 | Buy | 00.00% | View details for HC Wainwright rating of CytomX Therapeutics (NASDAQ:CTMX) on 5/11/2026 |
KEEL Keel Infrastructure | $4.23 +0.5% | 5/11/2026 | | Boost Price Target | $3.70 ➝ $5.50 | Accumulate ➝ Buy | 00.00% | View details for HC Wainwright rating of Keel Infrastructure (NASDAQ:KEEL) on 5/11/2026 |
MLTX MoonLake Immunotherapeutics | $17.05 +4.2% | 5/11/2026 | | Boost Price Target | $40.00 ➝ $45.00 | Buy | 00.00% | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 5/11/2026 |
NAGE Niagen Bioscience | $3.75 +2.2% | 5/11/2026 | | Lower Price Target | $12.00 ➝ $11.00 | Buy | 00.00% | View details for HC Wainwright rating of Niagen Bioscience (NASDAQ:NAGE) on 5/11/2026 |
VNDA Vanda Pharmaceuticals | $6.18 +3.2% | 5/11/2026 | | Lower Price Target | $24.00 ➝ $21.00 | Buy | 00.00% | View details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 5/11/2026 |
COIN Coinbase Global | $191.29 -1.1% | 5/8/2026 | | Lower Price Target | $350.00 ➝ $310.00 | Buy | 00.00% | View details for HC Wainwright rating of Coinbase Global (NASDAQ:COIN) on 5/8/2026 |
ARTV Artiva Biotherapeutics | $7.84 -8.3% | 5/8/2026 | | Boost Price Target | $15.00 ➝ $35.00 | Buy | 00.00% | View details for HC Wainwright rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 5/8/2026 |
INSM Insmed | $107.91 +0.5% | 5/8/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Insmed (NASDAQ:INSM) on 5/8/2026 |
GENB Generate Biomedicines | $13.02 +4.8% | 5/8/2026 | | Boost Price Target | $16.00 ➝ $25.00 | Buy | 00.00% | View details for HC Wainwright rating of Generate Biomedicines (NASDAQ:GENB) on 5/8/2026 |
TRDA Entrada Therapeutics | $6.04 +6.9% | 5/8/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Entrada Therapeutics (NASDAQ:TRDA) on 5/8/2026 |
SRRK Scholar Rock | $48.38 +1.7% | 5/8/2026 | | Boost Price Target | $58.00 ➝ $65.00 | Buy | 00.00% | View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 5/8/2026 |
VCEL Vericel | $35.40 +2.6% | 5/8/2026 | | Reiterated Rating | $64.00 | Buy | 00.00% | View details for HC Wainwright rating of Vericel (NASDAQ:VCEL) on 5/8/2026 |
UUUU Energy Fuels | $16.78 +3.7% | 5/8/2026 | | Boost Price Target | $27.25 ➝ $29.00 | Buy | 00.00% | View details for HC Wainwright rating of Energy Fuels (NYSEAMERICAN:UUUU) on 5/8/2026 |
ENGN enGene | $1.61 +5.2% | 5/8/2026 | | Lower Price Target | $25.00 ➝ $6.00 | Buy | 00.00% | View details for HC Wainwright rating of enGene (NASDAQ:ENGN) on 5/8/2026 |
Trump's gold order: the announcement they won't put on the front page (Ad) On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade.
Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction.
A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. Request the free guide in 30 seconds and get positioned now |
IREN IREN | $52.71 +10.4% | 5/8/2026 | | Boost Price Target | $85.00 | Buy | 00.00% | View details for HC Wainwright rating of IREN (NASDAQ:IREN) on 5/8/2026 |
GROY Gold Royalty | $3.22 +3.2% | 5/7/2026 | | Boost Price Target | $6.75 ➝ $7.75 | Buy | 00.00% | View details for HC Wainwright rating of Gold Royalty (NYSEAMERICAN:GROY) on 5/7/2026 |
MIRM Mirum Pharmaceuticals | $96.95 +1.4% | 5/7/2026 | | Set Price Target | $185.00 | | 00.00% | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 5/7/2026 |
SRZN Surrozen | $27.05 +5.8% | 5/7/2026 | | Reiterated Rating | $36.00 ➝ $44.00 | Buy | 00.00% | View details for HC Wainwright rating of Surrozen (NASDAQ:SRZN) on 5/7/2026 |
MNKD MannKind | $3.25 +9.8% | 5/7/2026 | | Boost Price Target | $8.00 ➝ $10.00 | Buy | 00.00% | View details for HC Wainwright rating of MannKind (NASDAQ:MNKD) on 5/7/2026 |
ALTO Alto Ingredients | $4.67 -1.1% | 5/7/2026 | | Boost Price Target | $5.50 ➝ $10.00 | Buy | 00.00% | View details for HC Wainwright rating of Alto Ingredients (NASDAQ:ALTO) on 5/7/2026 |
ATEC Alphatec | $8.24 +0.2% | 5/7/2026 | | Reiterated Rating | $24.00 | Buy | 00.00% | View details for HC Wainwright rating of Alphatec (NASDAQ:ATEC) on 5/7/2026 |
EXEL Exelixis | $49.90 +2.5% | 5/7/2026 | | Boost Price Target | $54.00 ➝ $56.00 | Buy | 00.00% | View details for HC Wainwright rating of Exelixis (NASDAQ:EXEL) on 5/7/2026 |
EXK Endeavour Silver | $9.36 +3.8% | 5/7/2026 | | Reiterated Rating | $17.00 | Buy | 00.00% | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 5/7/2026 |
TGTX TG Therapeutics | $39.76 +0.8% | 5/6/2026 | | Boost Price Target | $60.00 ➝ $70.00 | Buy | 00.00% | View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 5/6/2026 |